Pulmonx
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pulmonx's past years’ income statements indicate that its last revenue has increased compared to the previous period by 28% to $68,675,000. Profit margin reached -89%. Total operating expenses were $112,687,000.

Profit Margin

Pulmonx Corporation (NASDAQ:LUNG): Profit margin
2018 20.00M -18.47M -92.38%
2019 32.59M -20.70M -63.52%
2020 32.73M -32.23M -98.47%
2021 48.41M -48.66M -100.51%
2022 53.66M -58.92M -109.8%
2023 68.67M -60.84M -88.6%

LUNG Income Statement (2018 – 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
68.67M53.66M48.41M32.73M32.59M20.00M
Cost of revenue
17.92M13.79M12.78M11.53M10.18M7.71M
Gross profit
50.75M39.86M35.63M21.20M22.41M12.28M
Operating exp.
Research and development
18.08M15.39M13.06M7.46M6.04M6.99M
Selling and marketing
4.8M6.1M5.1M1.5M600K0
Total operating expenses
112.68M98.50M82.93M53.53M40.25M27.33M
Operating income
-61.93M-58.63M-47.30M-32.33M-17.83M-15.05M
Other income (expenses), net
1.66M67K-1.01M314K-2.50M-916K
Income before tax
-60.27M-58.57M-48.31M-32.01M-20.34M-18.46M
Income tax expense
571K353K343K213K363K12K
Net income
-60.84M-58.92M-48.66M-32.23M-20.70M-18.47M
Earnings per share
Basic EPS
-1.6-1.59-1.35-0.9-0.58-0.89
Diluted EPS
-1.6-1.59-1.35-0.9-0.58-0.89
Data sourceData sourceData sourceData source